Cargando…
Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results
Liposarcoma is one of the most common adult soft tissue sarcomas an consists of three histologic subtypes (well and dedifferentiated, myxoid/round cell, and pleomorphic). Surgery is the mainstay of treatment for localized disease; however for unresectable or metastatic disease, effective treatment o...
Autores principales: | Tseng, William W., Somaiah, Neeta, Lazar, Alexander J., Lev, Dina C., Pollock, Raphael E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730323/ https://www.ncbi.nlm.nih.gov/pubmed/24216990 http://dx.doi.org/10.3390/cancers5020529 |
Ejemplares similares
-
Overview of systemic therapy options in liposarcoma, with a focus on the activity of selinexor, a selective inhibitor of nuclear export in dedifferentiated liposarcoma
por: Thirasastr, Prapassorn, et al.
Publicado: (2022) -
Analysis of the Intratumoral Adaptive Immune Response in Well Differentiated and Dedifferentiated Retroperitoneal Liposarcoma
por: Tseng, William W., et al.
Publicado: (2015) -
Recent advances in the management of liposarcoma
por: Nassif, Nadar A., et al.
Publicado: (2016) -
The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcoma
por: Bill, Kate Lynn J., et al.
Publicado: (2015) -
Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma
por: Hwang, Ju-Ae, et al.
Publicado: (2014)